. 2007 Nov 1;196(9):1313–1320. doi: 10.1086/521304
© 2007 by the Infectious Diseases Society of America
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
Table 1.
Titers of antibodies specific for the trivalent vaccine.